Endovascular Today published an article in July 2014 in which three doctors well-versed in dealing with inferior vena cava (IVC) filters were interviewed for their opinions on indications, patient follow-up & retrieval rates and the prophylactic use of the devices.
Justinian Lane
Justinian Lane is a legal publisher specializing in asbestos and mesothelioma claims, operated as a division of Justinian C. Lane, Esq. – PLLC. The organization provides detailed information on asbestos litigation, related diseases, and compensation claims, including guidance on filing asbestos claims and understanding asbestos trusts. Their content covers various sources of asbestos exposure, symptoms, treatments, and legal history. The publisher also addresses related legal areas such as workers' compensation, veterans disability claims, and maritime claims. Justinian Lane maintains a database of asbestos trusts and offers resources for affected individuals seeking legal assistance and compensation.
Justinian Lane Blogs
Blog Authors
Latest from Justinian Lane
Summary: Inferior Vena Cava Filters in the United States: Less is More
In an article published in the International Journal of Cardiology in 2014, Drs. Mohamad Alkhouli and Riyaz Bashir question the efficacy of the inferior vena cava (IVC) filter as a device for routine use and raise cautions about the apparent…
Beginning of the End for Monsanto?
By Jared Fink
A former farm worker named Enrique Rubio may just be the right “David” to take down “Goliath” chemical company Monsanto. Rubio filed suit against the manufacturer of Roundup® early last week, claiming that the company’s infamous herbicide is the cause…
FDA Issued Serious Warning to C. R. Bard, Inc. Due to Multiple Violations
By Jared Fink
[By Staff Writer Jay Belle Isle]
In a letter dated July 13, the FDA issued serious warning to C. R. Bard Inc. due to multiple violations. The company has been given fifteen business days to respond to the letter or…
Postponement of Daubert Hearing in Zoloft Birth Defects Case
By Jared Fink
U.S. District Judge Cynthia Rufe or the Eastern District of Pennsylvania made the only call she could on Tuesday: the postponement of Daubert hearing in Zoloft birth defects case until September. The multidistrict litigation (MDL) against Pfizer, claiming its popular…
Drugs Disapproved by the FDA Deserve Attention
By Jared Fink
Recently, Reuters reported that “Drug companies generally don’t disclose all the reasons new medicines fail to win U.S. marketing approval, even though regulators often reject treatments over concerns about safety or effectiveness”.
Reporter Lisa Rapaport quotes Dr. Peter Lurie, FDA…
Fifth Circuit Releases Reglan Manufacturers from Birth Defect Liability
By Jared Fink
In an unpublished opinion file on April 9, the Court of Appeals for the 5th Circuit affirmed a previous decision in one of the Reglan generics cases, Whitener v. Pliva, Inc. This ruling upholds the district court’s grant of summary…
FDA: AndroGel, Low-T Drugs Must Warn for Heart Attack
By Jared Fink
On Tuesday March 3rd, the United States Food and Drug Administration required that manufacturers of testosterone supplements (or, Low-T drugs) include warnings on packaging for the increased risk for heart attack and stroke linked to these drugs.
In years…
Actos Manufacturer to Pay Millions in Cancer Lawsuit Settlement
By Jared Fink
Last week, the pharmaceutical company, Takeda, was ordered to pay $1.3 million in punitive damages to a former Philadelphia schoolteacher who “argued the drugmaker’s Actos diabetes medicine caused his bladder cancer”, Japan Times writes.
Only a few days earlier,…
2012 – 50% of IVC Filters Fail
By Jared Fink
In 2012 the Journal of the American Medical Association published an article titled “Frequent Fracture of TrapEase Inferior Vena Cava Filters,” providing further insight into one serious side effect related to the use of IVC filters. Inferior vena…